Physician Payments Disclosure & Aggregate Spend

Tuesday, October 16 to Wednesday, October 17, 2012

The Westin New York - Grand Central (formerly the NY Helmsley Hotel), New York City, NY

“Transparency must be thorough, data must be accurate, and data must have context for it to be useful.”
- Sen. Chuck Grassley and Sen. Herb Kohl,
authors of the Physician Payments Sunshine Act in a letter to CMS dated April 4, 2012

Companies are under urgent pressure to swiftly implement and manage a complete and integrated aggregate spend system in the next few months, even in the face of open questions about threshold definitions in the statute. Gain advanced strategies to incorporate immediately to meet the massive challenge of satisfying both federal and state disclosure requirements in an expedited timeframe.

Time is a luxury life sciences companies cannot afford to waste as the deadline for 2013 federal spend reporting inches closer. Complying with complicated and evolving federal, state, and global spend disclosure laws demands a massive amount of effort and resources, and companies must be compliant when doing business throughout the U.S. and abroad or else face severe monetary penalties and loss of crucial market share. ACI’s 4th Annual Forum on Physician Payments Disclosure and Aggregate Spend will save you time and money as a frontline faculty of drug and device manufacturers, government enforcers, and policy advisors help you formulate real-world, cost-effective strategies to streamline your systems and capture and report accurate and compliant spend data.

With a focus on improving existing compliance protocols in the face of the most stringent requirements yet, this is a solutions driven event. Attendees at all phases of aggregate spend implementation will leave this conference with practical tips and tried and true solutions to combat increasingly complex reporting requirements:

• BENCHMARK best practices against in-house leaders from Abbott, Bayer, CareFusion, Eli Lilly, GE Healthcare, Gilead, Pfizer, Medline Industries, Novo Nordisk, Tornier and many more who are developing solutions to the intense challenge of satisfying complex federal and state disclosure requirements while ensuring that corporate objectives are met.
• PREPARE for increasingly aggressive enforcement activity and public scrutiny as keynote speaker, James C. Cox, Medicaid Inspector General for New York, as well as prosecutors from the Vermont Office of the Attorney General and the U.S. Attorney’s Office for the Districts of Massachusetts and New Jersey reveal how enforcers may view disclosed data.
• GAIN the most up to date and thorough analysis of state disclosure laws to take back to your entire aggregate spend team in the Pre-Conference State Law Boot Camp: Comprehensive State-by-State Breakdown of Disclosure and Reporting Requirements, featuring insights into pending state legislation from Delegate Dan K. Morhaim, Deputy Majority Leader, Maryland House of Delegates and a look at what states have done with the data received so far from Cody Wiberg, Executive Director of the Minnesota Board of Pharmacy.
• PROTECT relationships with healthcare professionals and consumers while creating a compliant system for capturing payments under disclosure laws.

For device manufacturers exclusively, the post-conference Comprehensive Aggregate Spend Solutions for Medical Device Manufacturers provides an intimate and collegial environment for attendees to discuss the unique logistical and practical issues facing the industry when reporting and disclosing payments to physicians.

Join your colleagues who are going through this process alongside you and walk away with real life examples and the most current advice on structuring and managing a comprehensive and viable aggregate spend system by calling 888-224-2480, faxing your registration form to 877-927-1563 or registering online.

Brochure

- click image for pdf -

- Actions -

- Share -

Location:
The Westin New York - Grand Central (formerly the NY Helmsley Hotel)
New York City, NY